カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のナノ医薬品市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Nanopharmaceutical Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19447）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19447
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：99
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のナノ医薬品市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

ナノ医薬品市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のナノ医薬品の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

ナノ医薬品市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・リポソーム、ポリマー、ナノクリスタル、タンパク質、その他

用途別セグメントは次のように区分されます。
・腫瘍学、神経学、免疫学、抗感染症、循環器、その他

世界のナノ医薬品市場の主要な市場プレーヤーは以下のとおりです。
・Pfizer、Merck、AstraZeneca、Gilead Sciences、Abbvie、Amgen、Roche、Novartis、Sanofi

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、ナノ医薬品製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なナノ医薬品メーカーの企業概要、2019年～2022年までのナノ医薬品の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なナノ医薬品メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別ナノ医薬品の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのナノ医薬品の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのナノ医薬品市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびナノ医薬品の産業チェーンを掲載しています。
・第13、14、15章では、ナノ医薬品の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- ナノ医薬品の概要
- 種類別分析（2017年vs2021年vs2028年）：リポソーム、ポリマー、ナノクリスタル、タンパク質、その他
- 用途別分析（2017年vs2021年vs2028年）：腫瘍学、神経学、免疫学、抗感染症、循環器、その他
- 世界のナノ医薬品市場規模・予測
- 世界のナノ医薬品生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Pfizer、Merck、AstraZeneca、Gilead Sciences、Abbvie、Amgen、Roche、Novartis、Sanofi
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：リポソーム、ポリマー、ナノクリスタル、タンパク質、その他
・用途別分析2017年-2028年：腫瘍学、神経学、免疫学、抗感染症、循環器、その他
・ナノ医薬品の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・ナノ医薬品のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・ナノ医薬品のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・ナノ医薬品の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・ナノ医薬品の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Nanopharmaceutical Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Nanopharmaceutical Drugs market size is estimated to be worth US$ 31860 million in 2021 and is forecast to a readjusted size of USD 71270 million by 2028 with a CAGR of 12.2% during review period. Oncology accounting for % of the Nanopharmaceutical Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Liposomes segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Nanopharmaceutical Drugs include Pfizer, Merck, AstraZeneca, Gilead Sciences, and Abbvie, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Nanopharmaceutical Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Liposomes
Polymer
Nanocrystals
Protein
Others
Market segment by Application can be divided into
Oncology
Neurology
Immunology
Anti-Infective
Cardiovascular
Others
The key market players for global Nanopharmaceutical Drugs market are listed below:
Pfizer
Merck
AstraZeneca
Gilead Sciences
Abbvie
Amgen
Roche
Novartis
Sanofi
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Nanopharmaceutical Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Nanopharmaceutical Drugs, with price, sales, revenue and global market share of Nanopharmaceutical Drugs from 2019 to 2022.
Chapter 3, the Nanopharmaceutical Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Nanopharmaceutical Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Nanopharmaceutical Drugs market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Nanopharmaceutical Drugs.
Chapter 13, 14, and 15, to describe Nanopharmaceutical Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Nanopharmaceutical Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Nanopharmaceutical Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Liposomes
1.2.3 Polymer
1.2.4 Nanocrystals
1.2.5 Protein
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Nanopharmaceutical Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Oncology
1.3.3 Neurology
1.3.4 Immunology
1.3.5 Anti-Infective
1.3.6 Cardiovascular
1.3.7 Others
1.4 Global Nanopharmaceutical Drugs Market Size & Forecast
1.4.1 Global Nanopharmaceutical Drugs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Nanopharmaceutical Drugs Sales in Volume (2017-2028)
1.4.3 Global Nanopharmaceutical Drugs Price (2017-2028)
1.5 Global Nanopharmaceutical Drugs Production Capacity Analysis
1.5.1 Global Nanopharmaceutical Drugs Total Production Capacity (2017-2028)
1.5.2 Global Nanopharmaceutical Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Nanopharmaceutical Drugs Market Drivers
1.6.2 Nanopharmaceutical Drugs Market Restraints
1.6.3 Nanopharmaceutical Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Nanopharmaceutical Drugs Product and Services
2.1.4 Pfizer Nanopharmaceutical Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck Nanopharmaceutical Drugs Product and Services
2.2.4 Merck Nanopharmaceutical Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 AstraZeneca
2.3.1 AstraZeneca Details
2.3.2 AstraZeneca Major Business
2.3.3 AstraZeneca Nanopharmaceutical Drugs Product and Services
2.3.4 AstraZeneca Nanopharmaceutical Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Gilead Sciences
2.4.1 Gilead Sciences Details
2.4.2 Gilead Sciences Major Business
2.4.3 Gilead Sciences Nanopharmaceutical Drugs Product and Services
2.4.4 Gilead Sciences Nanopharmaceutical Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Abbvie
2.5.1 Abbvie Details
2.5.2 Abbvie Major Business
2.5.3 Abbvie Nanopharmaceutical Drugs Product and Services
2.5.4 Abbvie Nanopharmaceutical Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Amgen
2.6.1 Amgen Details
2.6.2 Amgen Major Business
2.6.3 Amgen Nanopharmaceutical Drugs Product and Services
2.6.4 Amgen Nanopharmaceutical Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Roche
2.7.1 Roche Details
2.7.2 Roche Major Business
2.7.3 Roche Nanopharmaceutical Drugs Product and Services
2.7.4 Roche Nanopharmaceutical Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Novartis
2.8.1 Novartis Details
2.8.2 Novartis Major Business
2.8.3 Novartis Nanopharmaceutical Drugs Product and Services
2.8.4 Novartis Nanopharmaceutical Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Sanofi
2.9.1 Sanofi Details
2.9.2 Sanofi Major Business
2.9.3 Sanofi Nanopharmaceutical Drugs Product and Services
2.9.4 Sanofi Nanopharmaceutical Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Nanopharmaceutical Drugs Breakdown Data by Manufacturer
3.1 Global Nanopharmaceutical Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Nanopharmaceutical Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Nanopharmaceutical Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Nanopharmaceutical Drugs Manufacturer Market Share in 2021
3.4.2 Top 6 Nanopharmaceutical Drugs Manufacturer Market Share in 2021
3.5 Global Nanopharmaceutical Drugs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Nanopharmaceutical Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Nanopharmaceutical Drugs Market Size by Region
4.1.1 Global Nanopharmaceutical Drugs Sales in Volume by Region (2017-2028)
4.1.2 Global Nanopharmaceutical Drugs Revenue by Region (2017-2028)
4.2 North America Nanopharmaceutical Drugs Revenue (2017-2028)
4.3 Europe Nanopharmaceutical Drugs Revenue (2017-2028)
4.4 Asia-Pacific Nanopharmaceutical Drugs Revenue (2017-2028)
4.5 South America Nanopharmaceutical Drugs Revenue (2017-2028)
4.6 Middle East and Africa Nanopharmaceutical Drugs Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Nanopharmaceutical Drugs Sales in Volume by Type (2017-2028)
5.2 Global Nanopharmaceutical Drugs Revenue by Type (2017-2028)
5.3 Global Nanopharmaceutical Drugs Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Nanopharmaceutical Drugs Sales in Volume by Application (2017-2028)
6.2 Global Nanopharmaceutical Drugs Revenue by Application (2017-2028)
6.3 Global Nanopharmaceutical Drugs Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Nanopharmaceutical Drugs Sales by Type (2017-2028)
7.2 North America Nanopharmaceutical Drugs Sales by Application (2017-2028)
7.3 North America Nanopharmaceutical Drugs Market Size by Country
7.3.1 North America Nanopharmaceutical Drugs Sales in Volume by Country (2017-2028)
7.3.2 North America Nanopharmaceutical Drugs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Nanopharmaceutical Drugs Sales by Type (2017-2028)
8.2 Europe Nanopharmaceutical Drugs Sales by Application (2017-2028)
8.3 Europe Nanopharmaceutical Drugs Market Size by Country
8.3.1 Europe Nanopharmaceutical Drugs Sales in Volume by Country (2017-2028)
8.3.2 Europe Nanopharmaceutical Drugs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Nanopharmaceutical Drugs Sales by Type (2017-2028)
9.2 Asia-Pacific Nanopharmaceutical Drugs Sales by Application (2017-2028)
9.3 Asia-Pacific Nanopharmaceutical Drugs Market Size by Region
9.3.1 Asia-Pacific Nanopharmaceutical Drugs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Nanopharmaceutical Drugs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Nanopharmaceutical Drugs Sales by Type (2017-2028)
10.2 South America Nanopharmaceutical Drugs Sales by Application (2017-2028)
10.3 South America Nanopharmaceutical Drugs Market Size by Country
10.3.1 South America Nanopharmaceutical Drugs Sales in Volume by Country (2017-2028)
10.3.2 South America Nanopharmaceutical Drugs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Nanopharmaceutical Drugs Sales by Type (2017-2028)
11.2 Middle East & Africa Nanopharmaceutical Drugs Sales by Application (2017-2028)
11.3 Middle East & Africa Nanopharmaceutical Drugs Market Size by Country
11.3.1 Middle East & Africa Nanopharmaceutical Drugs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Nanopharmaceutical Drugs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Nanopharmaceutical Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Nanopharmaceutical Drugs
12.3 Nanopharmaceutical Drugs Production Process
12.4 Nanopharmaceutical Drugs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Nanopharmaceutical Drugs Typical Distributors
13.3 Nanopharmaceutical Drugs Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Nanopharmaceutical Drugs Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Nanopharmaceutical Drugs Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Nanopharmaceutical Drugs Product and Services
Table 6. Pfizer Nanopharmaceutical Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Merck Basic Information, Manufacturing Base and Competitors
Table 8. Merck Major Business
Table 9. Merck Nanopharmaceutical Drugs Product and Services
Table 10. Merck Nanopharmaceutical Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 12. AstraZeneca Major Business
Table 13. AstraZeneca Nanopharmaceutical Drugs Product and Services
Table 14. AstraZeneca Nanopharmaceutical Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 16. Gilead Sciences Major Business
Table 17. Gilead Sciences Nanopharmaceutical Drugs Product and Services
Table 18. Gilead Sciences Nanopharmaceutical Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Abbvie Basic Information, Manufacturing Base and Competitors
Table 20. Abbvie Major Business
Table 21. Abbvie Nanopharmaceutical Drugs Product and Services
Table 22. Abbvie Nanopharmaceutical Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Amgen Basic Information, Manufacturing Base and Competitors
Table 24. Amgen Major Business
Table 25. Amgen Nanopharmaceutical Drugs Product and Services
Table 26. Amgen Nanopharmaceutical Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Roche Basic Information, Manufacturing Base and Competitors
Table 28. Roche Major Business
Table 29. Roche Nanopharmaceutical Drugs Product and Services
Table 30. Roche Nanopharmaceutical Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Novartis Basic Information, Manufacturing Base and Competitors
Table 32. Novartis Major Business
Table 33. Novartis Nanopharmaceutical Drugs Product and Services
Table 34. Novartis Nanopharmaceutical Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Sanofi Basic Information, Manufacturing Base and Competitors
Table 36. Sanofi Major Business
Table 37. Sanofi Nanopharmaceutical Drugs Product and Services
Table 38. Sanofi Nanopharmaceutical Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Global Nanopharmaceutical Drugs Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K MT)
Table 40. Global Nanopharmaceutical Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 41. Market Position of Manufacturers in Nanopharmaceutical Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 42. Global Nanopharmaceutical Drugs Production Capacity by Company, (K MT): 2020 VS 2021
Table 43. Head Office and Nanopharmaceutical Drugs Production Site of Key Manufacturer
Table 44. Nanopharmaceutical Drugs New Entrant and Capacity Expansion Plans
Table 45. Nanopharmaceutical Drugs Mergers & Acquisitions in the Past Five Years
Table 46. Global Nanopharmaceutical Drugs Sales by Region (2017-2022) & (K MT)
Table 47. Global Nanopharmaceutical Drugs Sales by Region (2023-2028) & (K MT)
Table 48. Global Nanopharmaceutical Drugs Revenue by Region (2017-2022) & (USD Million)
Table 49. Global Nanopharmaceutical Drugs Revenue by Region (2023-2028) & (USD Million)
Table 50. Global Nanopharmaceutical Drugs Sales by Type (2017-2022) & (K MT)
Table 51. Global Nanopharmaceutical Drugs Sales by Type (2023-2028) & (K MT)
Table 52. Global Nanopharmaceutical Drugs Revenue by Type (2017-2022) & (USD Million)
Table 53. Global Nanopharmaceutical Drugs Revenue by Type (2023-2028) & (USD Million)
Table 54. Global Nanopharmaceutical Drugs Price by Type (2017-2022) & (USD/MT)
Table 55. Global Nanopharmaceutical Drugs Price by Type (2023-2028) & (USD/MT)
Table 56. Global Nanopharmaceutical Drugs Sales by Application (2017-2022) & (K MT)
Table 57. Global Nanopharmaceutical Drugs Sales by Application (2023-2028) & (K MT)
Table 58. Global Nanopharmaceutical Drugs Revenue by Application (2017-2022) & (USD Million)
Table 59. Global Nanopharmaceutical Drugs Revenue by Application (2023-2028) & (USD Million)
Table 60. Global Nanopharmaceutical Drugs Price by Application (2017-2022) & (USD/MT)
Table 61. Global Nanopharmaceutical Drugs Price by Application (2023-2028) & (USD/MT)
Table 62. North America Nanopharmaceutical Drugs Sales by Country (2017-2022) & (K MT)
Table 63. North America Nanopharmaceutical Drugs Sales by Country (2023-2028) & (K MT)
Table 64. North America Nanopharmaceutical Drugs Revenue by Country (2017-2022) & (USD Million)
Table 65. North America Nanopharmaceutical Drugs Revenue by Country (2023-2028) & (USD Million)
Table 66. North America Nanopharmaceutical Drugs Sales by Type (2017-2022) & (K MT)
Table 67. North America Nanopharmaceutical Drugs Sales by Type (2023-2028) & (K MT)
Table 68. North America Nanopharmaceutical Drugs Sales by Application (2017-2022) & (K MT)
Table 69. North America Nanopharmaceutical Drugs Sales by Application (2023-2028) & (K MT)
Table 70. Europe Nanopharmaceutical Drugs Sales by Country (2017-2022) & (K MT)
Table 71. Europe Nanopharmaceutical Drugs Sales by Country (2023-2028) & (K MT)
Table 72. Europe Nanopharmaceutical Drugs Revenue by Country (2017-2022) & (USD Million)
Table 73. Europe Nanopharmaceutical Drugs Revenue by Country (2023-2028) & (USD Million)
Table 74. Europe Nanopharmaceutical Drugs Sales by Type (2017-2022) & (K MT)
Table 75. Europe Nanopharmaceutical Drugs Sales by Type (2023-2028) & (K MT)
Table 76. Europe Nanopharmaceutical Drugs Sales by Application (2017-2022) & (K MT)
Table 77. Europe Nanopharmaceutical Drugs Sales by Application (2023-2028) & (K MT)
Table 78. Asia-Pacific Nanopharmaceutical Drugs Sales by Region (2017-2022) & (K MT)
Table 79. Asia-Pacific Nanopharmaceutical Drugs Sales by Region (2023-2028) & (K MT)
Table 80. Asia-Pacific Nanopharmaceutical Drugs Revenue by Region (2017-2022) & (USD Million)
Table 81. Asia-Pacific Nanopharmaceutical Drugs Revenue by Region (2023-2028) & (USD Million)
Table 82. Asia-Pacific Nanopharmaceutical Drugs Sales by Type (2017-2022) & (K MT)
Table 83. Asia-Pacific Nanopharmaceutical Drugs Sales by Type (2023-2028) & (K MT)
Table 84. Asia-Pacific Nanopharmaceutical Drugs Sales by Application (2017-2022) & (K MT)
Table 85. Asia-Pacific Nanopharmaceutical Drugs Sales by Application (2023-2028) & (K MT)
Table 86. South America Nanopharmaceutical Drugs Sales by Country (2017-2022) & (K MT)
Table 87. South America Nanopharmaceutical Drugs Sales by Country (2023-2028) & (K MT)
Table 88. South America Nanopharmaceutical Drugs Revenue by Country (2017-2022) & (USD Million)
Table 89. South America Nanopharmaceutical Drugs Revenue by Country (2023-2028) & (USD Million)
Table 90. South America Nanopharmaceutical Drugs Sales by Type (2017-2022) & (K MT)
Table 91. South America Nanopharmaceutical Drugs Sales by Type (2023-2028) & (K MT)
Table 92. South America Nanopharmaceutical Drugs Sales by Application (2017-2022) & (K MT)
Table 93. South America Nanopharmaceutical Drugs Sales by Application (2023-2028) & (K MT)
Table 94. Middle East & Africa Nanopharmaceutical Drugs Sales by Region (2017-2022) & (K MT)
Table 95. Middle East & Africa Nanopharmaceutical Drugs Sales by Region (2023-2028) & (K MT)
Table 96. Middle East & Africa Nanopharmaceutical Drugs Revenue by Region (2017-2022) & (USD Million)
Table 97. Middle East & Africa Nanopharmaceutical Drugs Revenue by Region (2023-2028) & (USD Million)
Table 98. Middle East & Africa Nanopharmaceutical Drugs Sales by Type (2017-2022) & (K MT)
Table 99. Middle East & Africa Nanopharmaceutical Drugs Sales by Type (2023-2028) & (K MT)
Table 100. Middle East & Africa Nanopharmaceutical Drugs Sales by Application (2017-2022) & (K MT)
Table 101. Middle East & Africa Nanopharmaceutical Drugs Sales by Application (2023-2028) & (K MT)
Table 102. Nanopharmaceutical Drugs Raw Material
Table 103. Key Manufacturers of Nanopharmaceutical Drugs Raw Materials
Table 104. Direct Channel Pros & Cons
Table 105. Indirect Channel Pros & Cons
Table 106. Nanopharmaceutical Drugs Typical Distributors
Table 107. Nanopharmaceutical Drugs Typical Customers
List of Figures
Figure 1. Nanopharmaceutical Drugs Picture
Figure 2. Global Nanopharmaceutical Drugs Revenue Market Share by Type in 2021
Figure 3. Liposomes
Figure 4. Polymer
Figure 5. Nanocrystals
Figure 6. Protein
Figure 7. Others
Figure 8. Global Nanopharmaceutical Drugs Revenue Market Share by Application in 2021
Figure 9. Oncology
Figure 10. Neurology
Figure 11. Immunology
Figure 12. Anti-Infective
Figure 13. Cardiovascular
Figure 14. Others
Figure 15. Global Nanopharmaceutical Drugs Revenue, (USD Million) & (K MT): 2017 & 2021 & 2028
Figure 16. Global Nanopharmaceutical Drugs Revenue and Forecast (2017-2028) & (USD Million)
Figure 17. Global Nanopharmaceutical Drugs Sales (2017-2028) & (K MT)
Figure 18. Global Nanopharmaceutical Drugs Price (2017-2028) & (USD/MT)
Figure 19. Global Nanopharmaceutical Drugs Production Capacity (2017-2028) & (K MT)
Figure 20. Global Nanopharmaceutical Drugs Production Capacity by Geographic Region: 2022 VS 2028
Figure 21. Nanopharmaceutical Drugs Market Drivers
Figure 22. Nanopharmaceutical Drugs Market Restraints
Figure 23. Nanopharmaceutical Drugs Market Trends
Figure 24. Global Nanopharmaceutical Drugs Sales Market Share by Manufacturer in 2021
Figure 25. Global Nanopharmaceutical Drugs Revenue Market Share by Manufacturer in 2021
Figure 26. Nanopharmaceutical Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 27. Top 3 Nanopharmaceutical Drugs Manufacturer (Revenue) Market Share in 2021
Figure 28. Top 6 Nanopharmaceutical Drugs Manufacturer (Revenue) Market Share in 2021
Figure 29. Global Nanopharmaceutical Drugs Sales Market Share by Region (2017-2028)
Figure 30. Global Nanopharmaceutical Drugs Revenue Market Share by Region (2017-2028)
Figure 31. North America Nanopharmaceutical Drugs Revenue (2017-2028) & (USD Million)
Figure 32. Europe Nanopharmaceutical Drugs Revenue (2017-2028) & (USD Million)
Figure 33. Asia-Pacific Nanopharmaceutical Drugs Revenue (2017-2028) & (USD Million)
Figure 34. South America Nanopharmaceutical Drugs Revenue (2017-2028) & (USD Million)
Figure 35. Middle East & Africa Nanopharmaceutical Drugs Revenue (2017-2028) & (USD Million)
Figure 36. Global Nanopharmaceutical Drugs Sales Market Share by Type (2017-2028)
Figure 37. Global Nanopharmaceutical Drugs Revenue Market Share by Type (2017-2028)
Figure 38. Global Nanopharmaceutical Drugs Price by Type (2017-2028) & (USD/MT)
Figure 39. Global Nanopharmaceutical Drugs Sales Market Share by Application (2017-2028)
Figure 40. Global Nanopharmaceutical Drugs Revenue Market Share by Application (2017-2028)
Figure 41. Global Nanopharmaceutical Drugs Price by Application (2017-2028) & (USD/MT)
Figure 42. North America Nanopharmaceutical Drugs Sales Market Share by Type (2017-2028)
Figure 43. North America Nanopharmaceutical Drugs Sales Market Share by Application (2017-2028)
Figure 44. North America Nanopharmaceutical Drugs Sales Market Share by Country (2017-2028)
Figure 45. North America Nanopharmaceutical Drugs Revenue Market Share by Country (2017-2028)
Figure 46. United States Nanopharmaceutical Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Canada Nanopharmaceutical Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Mexico Nanopharmaceutical Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Europe Nanopharmaceutical Drugs Sales Market Share by Type (2017-2028)
Figure 50. Europe Nanopharmaceutical Drugs Sales Market Share by Application (2017-2028)
Figure 51. Europe Nanopharmaceutical Drugs Sales Market Share by Country (2017-2028)
Figure 52. Europe Nanopharmaceutical Drugs Revenue Market Share by Country (2017-2028)
Figure 53. Germany Nanopharmaceutical Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. France Nanopharmaceutical Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. United Kingdom Nanopharmaceutical Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Russia Nanopharmaceutical Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Italy Nanopharmaceutical Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Asia-Pacific Nanopharmaceutical Drugs Sales Market Share by Region (2017-2028)
Figure 59. Asia-Pacific Nanopharmaceutical Drugs Sales Market Share by Application (2017-2028)
Figure 60. Asia-Pacific Nanopharmaceutical Drugs Sales Market Share by Region (2017-2028)
Figure 61. Asia-Pacific Nanopharmaceutical Drugs Revenue Market Share by Region (2017-2028)
Figure 62. China Nanopharmaceutical Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Japan Nanopharmaceutical Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Korea Nanopharmaceutical Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. India Nanopharmaceutical Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Southeast Asia Nanopharmaceutical Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Australia Nanopharmaceutical Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. South America Nanopharmaceutical Drugs Sales Market Share by Type (2017-2028)
Figure 69. South America Nanopharmaceutical Drugs Sales Market Share by Application (2017-2028)
Figure 70. South America Nanopharmaceutical Drugs Sales Market Share by Country (2017-2028)
Figure 71. South America Nanopharmaceutical Drugs Revenue Market Share by Country (2017-2028)
Figure 72. Brazil Nanopharmaceutical Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Argentina Nanopharmaceutical Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Middle East & Africa Nanopharmaceutical Drugs Sales Market Share by Type (2017-2028)
Figure 75. Middle East & Africa Nanopharmaceutical Drugs Sales Market Share by Application (2017-2028)
Figure 76. Middle East & Africa Nanopharmaceutical Drugs Sales Market Share by Region (2017-2028)
Figure 77. Middle East & Africa Nanopharmaceutical Drugs Revenue Market Share by Region (2017-2028)
Figure 78. Turkey Nanopharmaceutical Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Egypt Nanopharmaceutical Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Saudi Arabia Nanopharmaceutical Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. South Africa Nanopharmaceutical Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 82. Manufacturing Cost Structure Analysis of Nanopharmaceutical Drugs in 2021
Figure 83. Manufacturing Process Analysis of Nanopharmaceutical Drugs
Figure 84. Nanopharmaceutical Drugs Industrial Chain
Figure 85. Sales Channel: Direct Channel vs Indirect Channel
Figure 86. Methodology
Figure 87. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界のオシメルチニブ医薬品市場2022年：市場規模予測（～2028年）
  • 世界のエクセナチド薬物市場2022年：市場規模予測（～2028年）
  • 世界のペガスパルガーゼ薬物市場2022年：市場規模予測（～2028年）
  • 世界のリロナセプト薬物市場2022年：市場規模予測（～2028年）
  • 世界のブリナツモマブ治療薬市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19447 )"世界のナノ医薬品市場2022年：市場規模予測（～2028年）" (英文：Global Nanopharmaceutical Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。